A Multi-center, Double-blind, Placebo-controlled, Randomized Safety and Efficacy Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum in Pediatric Subjects

Trial Profile

A Multi-center, Double-blind, Placebo-controlled, Randomized Safety and Efficacy Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum in Pediatric Subjects

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Santalum album (Primary)
  • Indications Molluscum contagiosum
  • Focus Adverse reactions
  • Sponsors Santalis Healthcare Corporation
  • Most Recent Events

    • 23 Oct 2017 Status changed from recruiting to discontinued.
    • 16 May 2017 Planned End Date changed from 1 Nov 2016 to 1 Nov 2017.
    • 16 May 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top